Literature DB >> 16517715

GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells.

John Shoemaker1, Margarida Saraiva, Anne O'Garra.   

Abstract

IL-10 is a major regulator in inflammatory responses. Although various transcription factors were defined to enhance IL-10, the molecular mechanism for the initiation of Il-10 transcription, remains unknown. mRNA profiling of six distinct primary CD4+ T cell populations showed differential expression of the transcription factor GATA-3 correlated with levels of IL-10 expression. We showed that ectopic expression of GATA-3 in naive primary CD4+ T cells enhanced expression of IL-10 by these cells and uncovered a possible mechanism for this effect. We found that GATA-3 induced changes of the chromatin structure at the Il-10 locus and that these changes occur even in the absence of IL-4. Furthermore we found that in the presence of GATA-3 the histones at the Il-10 locus become acetylated. Despite being recruited in vivo to two locations on the Il-10 locus, GATA-3 did not transactivate the IL-10 promoter. We therefore suggest a key role of GATA-3 in instructing Il-10 gene expression in primary CD4+ T cells, possibly by switching and stabilizing the Il-10 locus into a transcriptionally competent status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517715     DOI: 10.4049/jimmunol.176.6.3470

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Highlights of 10 years of immunology in Nature Reviews Immunology.

Authors:  Ruslan Medzhitov; Ethan M Shevach; Giorgio Trinchieri; Andrew L Mellor; David H Munn; Siamon Gordon; Peter Libby; Göran K Hansson; Ken Shortman; Chen Dong; Dmitry Gabrilovich; Leona Gabryšová; Ashleigh Howes; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

2.  Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription.

Authors:  Xia Zhang; Justin P Edwards; David M Mosser
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

3.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation.

Authors:  S M Coomes; Y Kannan; V S Pelly; L J Entwistle; R Guidi; J Perez-Lloret; N Nikolov; W Müller; M S Wilson
Journal:  Mucosal Immunol       Date:  2016-05-11       Impact factor: 7.313

Review 5.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 6.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 7.  Epigenetic regulation of cytokine gene expression in T lymphocytes.

Authors:  Choong-Gu Lee; Anupama Sahoo; Sin-Hyeog Im
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

8.  Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population.

Authors:  Maris Kuningas; Linda May; Riin Tamm; David van Bodegom; Anita H J van den Biggelaar; Johannes J Meij; Marijke Frölich; Juventus B Ziem; Helena E D Suchiman; Andres Metspalu; P Eline Slagboom; Rudi G J Westendorp
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

9.  Dishing the dirt on asthma: What we can learn from poor hygiene.

Authors:  Catherine de Lara; Alistair Noble
Journal:  Biologics       Date:  2007-06

10.  Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.

Authors:  Margarida Saraiva; Jillian R Christensen; Marc Veldhoen; Theresa L Murphy; Kenneth M Murphy; Anne O'Garra
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.